Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA

NCT05138289 is registered in ClinicalTrials.gov with HeartFlow, Inc. as lead sponsor.

NCT NCT05138289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05138289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
Lead sponsor
HeartFlow, Inc.
Phase
Observational
Overall status
Completed
Start date
October 12, 2021
Completion date
November 8, 2022
Enrollment
258 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd))